Is tepotinib available in the country?

The original drug of tepotinib (tepotinib) is a new type of drug. It has not yet been launched in China and has not been included in the medical insurance. Domestic patients cannot yet purchase this drug in pharmacies or hospitals. Tepotinib is an oral MET-targeted tyrosine kinase inhibitor that treats adult patients with metastatic non-small cell lung cancer (NSCLC). It works by blocking the activity of an abnormal protein that signals cancer cells to multiply, which helps slow or stop the spread of cancer cells. Since Tepotinib has been on the market for a short time, the overseas price of the original drug is around RMB 80,000 (the price may fluctuate due to exchange rate effects).